Eledon Pharmaceuticals, Inc. (ELDN) Financials
ELDN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 96.1 million | 4.7 million |
| 2023-06-30 | 106.8 million | 6.8 million |
| 2023-03-31 | 82.3 million | 7.5 million |
| 2022-12-31 | 92.8 million | 8.6 million |
ELDN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -12.3 million | 1.7 million |
| 2023-06-30 | -8.2 million | 1.7 million |
| 2023-03-31 | -9.9 million | 1.4 million |
| 2022-12-31 | -9.5 million | 1.5 million |
ELDN Net Income
No data available :(
ELDN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 59.6 million | - | 479000 |
| 2023-06-30 | 71.4 million | - | 574000 |
| 2023-03-31 | 46.5 million | - | 668000 |
| 2022-12-31 | 56.4 million | - | 746000 |
ELDN Shares Outstanding
ELDN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 7.9 million | 3.3 million | - |
| 2023-06-30 | - | 7.2 million | 3.2 million | - |
| 2023-03-31 | - | 8.1 million | 3.0 million | - |
| 2022-12-31 | - | 7.3 million | 2.8 million | - |
ELDN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 94000 |
| 2023-06-30 | - | 94000 |
| 2023-03-31 | - | 92000 |
| 2022-12-31 | - | 93000 |
ELDN
Price: $2.41
52 week price:
Earnings Per Share: -1.64 USD
P/E Ratio: -0.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 24400
Market Capitalization: 41.9 million